Controversies in the management of organophosphate pesticide poisoning

K. L. Bairy, Sudha Vidyasagar, Alok Sharma, V. Sammad

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Acute poisoning with organophosphorous (OP) pesticides frequently causes ill-health and death all over the world. The treatment of OP poisoning is primarily aimed at reversing the effects of the compound by administration of atropine. A second class of compounds-oximes, capable of regenerating the active enzyme from the OP-cholinesterase complex, is also available to treat OP poisoning. Pralidoxime is the oxime most often used worldwide. The low propensity to aging with diethyl organophosphorous poisoning may allow reactivation of the acetylcholinesterase after several days, when the poison concentration drops. The usefulness of oximes has however been challenged over the past 20 years by physicians in many parts of the world who have failed to see any benefit in their clinical practice. We have carried out a systematic search to find clinical trials, both randomized and nonrandomized involving the management of OP poisoning. The clinical benefits of oximes in OP poisoning is not clear, being limited by the type of OP, poison load, time to start therapy and dose of oximes. Hence, one is left with a doubt as to whether one could use oximes at all in OP poisoning? A high-quality randomized clinical trial on a large number of subjects comparing the current World Health Organization- recommended regimen with a placebo to assess the value of pralidoxime in acute OP poisoning, may answer the above question.

Original languageEnglish
Pages (from-to)71-74
Number of pages4
JournalIndian Journal of Pharmacology
Volume39
Issue number2
Publication statusPublished - 01-03-2007

Fingerprint

Organophosphate Poisoning
Pesticides
Poisoning
Oximes
Poisons
Randomized Controlled Trials
Cholinesterases
Acetylcholinesterase
Atropine
Placebos
Physicians

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Bairy, K. L. ; Vidyasagar, Sudha ; Sharma, Alok ; Sammad, V. / Controversies in the management of organophosphate pesticide poisoning. In: Indian Journal of Pharmacology. 2007 ; Vol. 39, No. 2. pp. 71-74.
@article{cb73d2ba98494d99b09ce806f97d64fc,
title = "Controversies in the management of organophosphate pesticide poisoning",
abstract = "Acute poisoning with organophosphorous (OP) pesticides frequently causes ill-health and death all over the world. The treatment of OP poisoning is primarily aimed at reversing the effects of the compound by administration of atropine. A second class of compounds-oximes, capable of regenerating the active enzyme from the OP-cholinesterase complex, is also available to treat OP poisoning. Pralidoxime is the oxime most often used worldwide. The low propensity to aging with diethyl organophosphorous poisoning may allow reactivation of the acetylcholinesterase after several days, when the poison concentration drops. The usefulness of oximes has however been challenged over the past 20 years by physicians in many parts of the world who have failed to see any benefit in their clinical practice. We have carried out a systematic search to find clinical trials, both randomized and nonrandomized involving the management of OP poisoning. The clinical benefits of oximes in OP poisoning is not clear, being limited by the type of OP, poison load, time to start therapy and dose of oximes. Hence, one is left with a doubt as to whether one could use oximes at all in OP poisoning? A high-quality randomized clinical trial on a large number of subjects comparing the current World Health Organization- recommended regimen with a placebo to assess the value of pralidoxime in acute OP poisoning, may answer the above question.",
author = "Bairy, {K. L.} and Sudha Vidyasagar and Alok Sharma and V. Sammad",
year = "2007",
month = "3",
day = "1",
language = "English",
volume = "39",
pages = "71--74",
journal = "Indian Journal of Pharmacology",
issn = "0253-7613",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

Controversies in the management of organophosphate pesticide poisoning. / Bairy, K. L.; Vidyasagar, Sudha; Sharma, Alok; Sammad, V.

In: Indian Journal of Pharmacology, Vol. 39, No. 2, 01.03.2007, p. 71-74.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Controversies in the management of organophosphate pesticide poisoning

AU - Bairy, K. L.

AU - Vidyasagar, Sudha

AU - Sharma, Alok

AU - Sammad, V.

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Acute poisoning with organophosphorous (OP) pesticides frequently causes ill-health and death all over the world. The treatment of OP poisoning is primarily aimed at reversing the effects of the compound by administration of atropine. A second class of compounds-oximes, capable of regenerating the active enzyme from the OP-cholinesterase complex, is also available to treat OP poisoning. Pralidoxime is the oxime most often used worldwide. The low propensity to aging with diethyl organophosphorous poisoning may allow reactivation of the acetylcholinesterase after several days, when the poison concentration drops. The usefulness of oximes has however been challenged over the past 20 years by physicians in many parts of the world who have failed to see any benefit in their clinical practice. We have carried out a systematic search to find clinical trials, both randomized and nonrandomized involving the management of OP poisoning. The clinical benefits of oximes in OP poisoning is not clear, being limited by the type of OP, poison load, time to start therapy and dose of oximes. Hence, one is left with a doubt as to whether one could use oximes at all in OP poisoning? A high-quality randomized clinical trial on a large number of subjects comparing the current World Health Organization- recommended regimen with a placebo to assess the value of pralidoxime in acute OP poisoning, may answer the above question.

AB - Acute poisoning with organophosphorous (OP) pesticides frequently causes ill-health and death all over the world. The treatment of OP poisoning is primarily aimed at reversing the effects of the compound by administration of atropine. A second class of compounds-oximes, capable of regenerating the active enzyme from the OP-cholinesterase complex, is also available to treat OP poisoning. Pralidoxime is the oxime most often used worldwide. The low propensity to aging with diethyl organophosphorous poisoning may allow reactivation of the acetylcholinesterase after several days, when the poison concentration drops. The usefulness of oximes has however been challenged over the past 20 years by physicians in many parts of the world who have failed to see any benefit in their clinical practice. We have carried out a systematic search to find clinical trials, both randomized and nonrandomized involving the management of OP poisoning. The clinical benefits of oximes in OP poisoning is not clear, being limited by the type of OP, poison load, time to start therapy and dose of oximes. Hence, one is left with a doubt as to whether one could use oximes at all in OP poisoning? A high-quality randomized clinical trial on a large number of subjects comparing the current World Health Organization- recommended regimen with a placebo to assess the value of pralidoxime in acute OP poisoning, may answer the above question.

UR - http://www.scopus.com/inward/record.url?scp=34250187436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250187436&partnerID=8YFLogxK

M3 - Review article

VL - 39

SP - 71

EP - 74

JO - Indian Journal of Pharmacology

JF - Indian Journal of Pharmacology

SN - 0253-7613

IS - 2

ER -